Literature DB >> 17123562

Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice.

Adam C Straub1, Donna B Stolz, Harina Vin, Mark A Ross, Nicole V Soucy, Linda R Klei, Aaron Barchowsky.   

Abstract

The vascular effects of arsenic in drinking water are global health concerns contributing to human disease worldwide. Arsenic targets the endothelial cells lining blood vessels, and endothelial cell activation or dysfunction may underlie the pathogenesis of both arsenic-induced vascular diseases and arsenic-enhanced tumorigenesis. The purpose of the current studies was to demonstrate that exposing mice to drinking water containing environmentally relevant levels of arsenic promoted endothelial cell dysfunction and pathologic vascular remodeling. Increased angiogenesis, neovascularization, and inflammatory cell infiltration were observed in Matrigel plugs implanted in C57BL/6 mice following 5-week exposures to 5-500 ppb arsenic [Soucy, N.V., Mayka, D., Klei, L.R., Nemec, A.A., Bauer, J.A., Barchowsky, A., 2005. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc.Toxicol 5, 29-42]. Therefore, functional in vivo effects of arsenic on endothelial cell function and vessel remodeling in an endogenous vascular bed were investigated in the liver. Liver sinusoidal endothelial cells (LSEC) became progressively defenestrated and underwent capillarization to decrease vessel porosity following exposure to 250 ppb arsenic for 2 weeks. Sinusoidal expression of PECAM-1 and laminin-1 proteins, a hallmark of capillarization, was also increased by 2 weeks of exposure. LSEC caveolin-1 protein and caveolae expression were induced after 2 weeks of exposure indicating a compensatory change. Likewise, CD45/CD68-positive inflammatory cells did not accumulate in the livers until after LSEC porosity was decreased, indicating that inflammation is a consequence and not a cause of the arsenic-induced LSEC phenotype. The data demonstrate that the liver vasculature is an early target of pathogenic arsenic effects and that the mouse liver vasculature is a sensitive model for investigating vascular health effects of arsenic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123562      PMCID: PMC2084367          DOI: 10.1016/j.taap.2006.10.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  56 in total

1.  A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis.

Authors:  K Tsuneyama; K Ohba; Y Zen; Y Sato; H Niwa; H Minato; Y Nakanuma
Journal:  Histopathology       Date:  2003-07       Impact factor: 5.087

Review 2.  VEGF-induced angiogenesis drives collateral circulation in portal hypertension.

Authors:  Richard Moreau
Journal:  J Hepatol       Date:  2005-04-26       Impact factor: 25.083

3.  Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.

Authors:  Kazuyuki Shigeno; Kensuke Naito; Naohi Sahara; Miki Kobayashi; Satoki Nakamura; Sinya Fujisawa; Kaori Shinjo; Akihiro Takeshita; Ryuzo Ohno; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

4.  Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells.

Authors:  A Barchowsky; E J Dudek; M D Treadwell; K E Wetterhahn
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 5.  Vascular effects of chronic arsenic exposure: a review.

Authors:  R R Engel; C Hopenhayn-Rich; O Receveur; A H Smith
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

6.  Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver.

Authors:  A Couvelard; J Y Scoazec; G Feldmann
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Arsenic induced apoptosis in rat liver following repeated 60 days exposure.

Authors:  Somia Bashir; Yukti Sharma; M Irshad; T C Nag; Monica Tiwari; M Kabra; T D Dogra
Journal:  Toxicology       Date:  2005-11-09       Impact factor: 4.221

8.  Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration.

Authors:  D B Stolz; M A Ross; H M Salem; W M Mars; G K Michalopoulos; K Enomoto
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

9.  Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study.

Authors:  L Dubuisson; L Boussarie; C A Bedin; C Balabaud; P Bioulac-Sage
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

10.  The effects of oxidative stress on the liver sieve.

Authors:  Victoria C Cogger; Michael Muller; Robin Fraser; Allan J McLean; Jameel Khan; David G Le Couteur
Journal:  J Hepatol       Date:  2004-09       Impact factor: 25.083

View more
  24 in total

1.  Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Ernesto L Schiffrin; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

Review 2.  Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.

Authors:  Imad Al Ghouleh; Nicholas K H Khoo; Ulla G Knaus; Kathy K Griendling; Rhian M Touyz; Victor J Thannickal; Aaron Barchowsky; William M Nauseef; Eric E Kelley; Phillip M Bauer; Victor Darley-Usmar; Sruti Shiva; Eugenia Cifuentes-Pagano; Bruce A Freeman; Mark T Gladwin; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2011-06-14       Impact factor: 7.376

3.  Identification of Id1 as a downstream effector for arsenic-promoted angiogenesis via PI3K/Akt, NF-κB and NOS signaling.

Authors:  Chun-Hao Tsai; Ming-Hui Yang; Amos C Hung; Shou-Cheng Wu; Wen-Chin Chiu; Ming-Feng Hou; Yu-Chang Tyan; Yun-Ming Wang; Shyng-Shiou F Yuan
Journal:  Toxicol Res (Camb)       Date:  2015-10-05       Impact factor: 3.524

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 5.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

6.  Evaluation of vascular effect of arsenic using in vivo assays.

Authors:  Bharat Patel; Rajat Das; Anil Gautam; Mugdha Tiwari; Sukhdev Acharya; Sunil Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-17       Impact factor: 4.223

7.  Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response.

Authors:  Lisa Smeester; Paige A Bommarito; Elizabeth M Martin; Rogelio Recio-Vega; Tania Gonzalez-Cortes; Edgar Olivas-Calderon; R Clark Lantz; Rebecca C Fry
Journal:  Environ Toxicol Pharmacol       Date:  2017-04-08       Impact factor: 4.860

8.  Perturbation of defense pathways by low-dose arsenic exposure in zebrafish embryos.

Authors:  Carolyn J Mattingly; Thomas H Hampton; Kimberly M Brothers; Nina E Griffin; Antonio Planchart
Journal:  Environ Health Perspect       Date:  2009-02-22       Impact factor: 9.031

9.  Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006.

Authors:  Ana Navas-Acien; Ellen K Silbergeld; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

10.  Arsenic requires sphingosine-1-phosphate type 1 receptors to induce angiogenic genes and endothelial cell remodeling.

Authors:  Adam C Straub; Linda R Klei; Donna B Stolz; Aaron Barchowsky
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.